Biostar Pharmaceuticals
Welcome to Chinasecurities
February 13, 2009
The report, Investing in China's Pharmaceutical Industry, is the second edition of a paper published by PricewaterhouseCoopers looking into the current pharmaceutical market conditions in China. It covers various subjects that are considered to be of concern to the pharmaceutical industry and/or investors in the pharmaceutical industry in China.